Interaction of the antiepileptic drug lamotrigine with recombinant rat brain type IIA Na+ channels and with native Na+ channels in rat hippocampal neurones

Actions of the new antiepileptic drug lamotrigine (LTG, Lamictal) were characterised using recombinant rat brain type IIA Na+ channels expressed in Chinese hamster ovary (CHO) cells and native Na+ channels in rat hippocampal pyramidal neurones, using whole-cell recording and intracellular recording techniques. In CHO cells, LTG caused a tonic inhibition of Na+ currents in a concentration-dependent and voltage-dependent manner. The half-maximal inhibitory concentration (IC50) of approximately 500 μM was obtained at a holding potential (Vh) of −90 mV compared with an IC50 of 100 μM at a Vh of −60 mV. LTG (50 μM) caused a 10−mV negative shift in the slow, steady-state inactivation curve and delayed considerably the recovery from inactivation, but had no significant effects on the voltage dependence of activation or fast inactivation, suggesting that LTG acts mainly on the slow inactivated state. The affinity for the inactivated channels was estimated at 12 μM. The tonic inhibition was augmented by a use-dependent action in which a further inhibition by the drug developed during rapid repetitive stimulation using a train of 20-ms duration pulses (11 Hz). These results were consistent with the drug action being on firing properties of pyramidal neurones. Only in those epileptiform bursts which caused cumulative inactivation of Na+ spikes did LTG produce a potent inhibition. Our data suggest that the inactivated channel is a primary target for LTG action at therapeutic concentrations.

[1]  P. Ruben,et al.  Steady-state availability of sodium channels. Interactions between activation and slow inactivation. , 1992, Biophysical journal.

[2]  K. Courtney,et al.  Modulated anticonvulsant block of sodium channels in nerve and muscle. , 1983, European journal of pharmacology.

[3]  R J Dunn,et al.  Block of the rat brain IIA sodium channel alpha subunit by the neuroprotective drug riluzole. , 1994, Molecular pharmacology.

[4]  M. Brodie,et al.  Lamotrigine versus other antiepileptic drugs: a star rating system is born. , 1994, Epilepsia.

[5]  T. Narahashi,et al.  Modification of single Na+ channels by batrachotoxin. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[6]  D. Escande,et al.  Riluzole specifically blocks inactivated Na channels in myelinated nerve fibre , 1991, Pflügers Archiv.

[7]  B. Cooper,et al.  Lamotrigine, phenytoin and carbamazepine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. , 1993, The Journal of pharmacology and experimental therapeutics.

[8]  N. Matsuki,et al.  Characterization of the block of sodium channels by phenytoin in mouse neuroblastoma cells. , 1984, The Journal of pharmacology and experimental therapeutics.

[9]  M. Leach,et al.  Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex , 1993, Brain Research.

[10]  M. Leach,et al.  Pharmacological Studies on Lamotrigine, A Novel Potential Antiepileptic Drug , 1986, Epilepsia.

[11]  W. Catterall,et al.  Functional properties of rat brain sodium channels expressed in a somatic cell line. , 1990, Science.

[12]  W. Catterall,et al.  Frequency and voltage-dependent inhibition of type IIA Na+ channels, expressed in a mammalian cell line, by local anesthetic, antiarrhythmic, and anticonvulsant drugs. , 1991, Molecular pharmacology.

[13]  M. G. Baxter,et al.  Neurochemical and Behavioral Aspects of Lamotrigine , 1991, Epilepsia.

[14]  E. Harris,et al.  An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels , 1992, Epilepsy Research.

[15]  R. Nicoll,et al.  Control of the repetitive discharge of rat CA 1 pyramidal neurones in vitro. , 1984, The Journal of physiology.

[16]  M A Rogawski,et al.  Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. , 1990, Pharmacological reviews.

[17]  K. Goa,et al.  Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy. , 1993, Drugs.

[18]  G. Strichartz,et al.  The Inhibition of Sodium Currents in Myelinated Nerve by Quaternary Derivatives of Lidocaine , 1973, The Journal of general physiology.

[19]  W. Catterall,et al.  Restoration of inactivation and block of open sodium channels by an inactivation gate peptide , 1994, Neuron.

[20]  R. Macdonald,et al.  Mechanisms of Action of Currently Prescribed and Newly Developed Antiepileptic Drugs , 1994, Epilepsia.

[21]  K. Courtney.  Mechanism of frequency-dependent inhibition of sodium currents in frog myelinated nerve by the lidocaine derivative GEA. , 1975, The Journal of pharmacology and experimental therapeutics.

[22]  William A. Catterall,et al.  Differential subcellular localization of the RI and RII Na+ channel subtypes in central neurons , 1989, Neuron.

[23]  B. Sakmann,et al.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches , 1981, Pflügers Archiv.

[24]  W. Catterall,et al.  Cellular and molecular biology of voltage-gated sodium channels. , 1992, Physiological reviews.

[25]  F. N. Quandt.  Modification of slow inactivation of single sodium channels by phenytoin in neuroblastoma cells. , 1988, Molecular pharmacology.

[26]  B. Hille,et al.  Local anesthetics: hydrophilic and hydrophobic pathways for the drug- receptor reaction , 1977, The Journal of general physiology.